The Cyclotron will be dedicated to the production of radiopharmaceuticals for diagnosing and treating critical illnesses worldwide.
“We selected IBA for its leading technology and unique know-how in developing high energy 70 MeV cyclotrons,” said Dr Sheldon Trubatch, AZI Corporate Secretary. “IBA’s expertise will allow us to reach our objectives of supplying medical isotopes for the diagnosis and treatment of critical illnesses worldwide.”
The Cyclone® 70 is a high energy and high current proton industrial cyclotron. IBA has sold three other Cyclone® 70 systems to date: the Cyclone® 70 (multiparticle version cyclotron) which has been fully operational for radioisotope production and research in France (Arronax project, Nantes) since 2011; the Cyclone® 70 at Zevacor Molecular in the USA is fully operational since 2015; and a third Cyclone® 70 currently under installation in Moscow, Russia.